Merck's stock change was less than S&P 500's daily loss and outperformed the Medical sector loss on July 19, 2025.

1 report, 1 independent Updated Jul 19

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Merck

Keep exploring

Part of

Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck. All 2 developments

Within Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck.

The entities involved

Merck
public company in Indonesia
- The Schwab U.S. Dividend Equity ETF now includes Procter & Gamble, Abbott Laboratories, and Merck among its top 10 holdings.Sat 13:06
- Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.Fri 21:56

Coverage

Newest first; wire copies grouped

Jul 19ZacksMerck (MRK) Falls More Steeply Than Broader Market: What Investors Need to Know Merck (MRK) closed the most recent trading day at $79.96, moving -1.91% from the previous trading session. The stock's